Microfluidic synthesis of organic nanoparticles
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
B01L-003/00
G01N-001/10
B01F-003/08
A61K-009/51
A61K-047/48
B01F-005/04
B01F-005/06
B01F-011/00
B01F-013/00
B01J-013/04
B01J-019/00
B82Y-030/00
A61K-009/16
출원번호
US-0306249
(2007-06-22)
등록번호
US-9381477
(2016-07-05)
국제출원번호
PCT/US2007/071901
(2007-06-22)
§371/§102 date
20090914
(20090914)
국제공개번호
WO2007/150030
(2007-12-27)
발명자
/ 주소
Karnik, Rohit
Gu, Frank X.
Basto, Pamela
Cannizzaro, Chris
Khademhosseini, Alireza
Langer, Robert S.
Farokhzad, Omid C.
출원인 / 주소
Massachusetts Institute of Technology
대리인 / 주소
Pabst Patent Group LLP
인용정보
피인용 횟수 :
1인용 특허 :
205
초록▼
The present invention provides microfluidic systems and methods for the production of particles (e.g., nanoparticles) for drug delivery. The present invention provides microfluidic devices useful for production of particles by nanoprecipitation. The present invention provides highly homogenous compo
The present invention provides microfluidic systems and methods for the production of particles (e.g., nanoparticles) for drug delivery. The present invention provides microfluidic devices useful for production of particles by nanoprecipitation. The present invention provides highly homogenous compositions of particles produced by inventive microfluidic devices.
대표청구항▼
1. A microfluidic system for producing organic particles comprising a device comprising a mixing apparatus and at least a center channel and an outer channel, and each channel has a cross-section independently selected from the group consisting of circular, oval, ovaloid, elliptical, and ellipsoid s
1. A microfluidic system for producing organic particles comprising a device comprising a mixing apparatus and at least a center channel and an outer channel, and each channel has a cross-section independently selected from the group consisting of circular, oval, ovaloid, elliptical, and ellipsoid shapes, that converge into the mixing apparatus, wherein the width and height of each channel is between approximately 1 μm and approximately 1000 μm, andat least one polymer solution not containing particles, and a non-solvent fluid for each polymer not containing particles, wherein the polymer solution forms polymeric particles in the non-solvent fluid upon mixing,wherein the at least center and outer channels are positioned so that the polymer solution and non-solvent fluid flowing through each channel are directed at one another within the mixing apparatus, andwherein the position of the channels can be varied to alter the direction of the polymer solution or non-solvent fluid into the mixing apparatus,the device further comprising means for controlling the flow rates through the channels either using pumps or applying pressure to focus the polymer solution into a narrow stream having a width which is smaller than the channel width within the mixing apparatus, orwherein the mixing apparatus is selected from the group consisting of chaotic advection mixers, zigzag mixers, droplet mixers, shear superposition mixers, T-mixers, mixers based on Tesla structures, and active mixers,wherein the polymer solution forms polymeric particles in the mixing apparatus. 2. The microfluidic system of claim 1, wherein the system comprises a central channel and at least one outer channel, wherein the central channel is the mixing apparatus, wherein the at least one outer channel joins the central channel at an angle, whereby the polymer solution and non-solvent fluid move by laminar flow through the channel, and whereby particles are produced by nanoprecipitation using hydrodynamic flow focusing. 3. The microfluidic system of claim 1, wherein the polymer solution forms organic polymeric particles. 4. The microfluidic system of claim 1, wherein the mixing apparatus is selected from the group consisting of a chaotic advection mixer, a herringbone mixer, a zigzag mixer, a droplet mixer, a mixer based on Tesla structures, and an active mixer. 5. The microfluidic system of claim 1, further comprising an outlet channel from the mixing apparatus. 6. The microfluidic system of claim 1, wherein the width or height of each channel is between approximately 1 μm and approximately 100 μm. 7. The microfluidic system of claim 1, wherein the channels are arranged in one plane relative to one another. 8. The microfluidic system of claim 1, comprising means for applying pressure to each channel. 9. The microfluidic system of claim 1, comprising a plurality of inlet channels which converge into the central channel. 10. The microfluidic system of claim 9, comprising at least three inlet channels. 11. The microfluidic system of claim 9, comprising at least five inlet channels. 12. The microfluidic system of claim 1, wherein the channels are composed of a material suitable for the flow of a polymer solvent and a polymer non-solvent fluid. 13. The microfluidic system of claim 12, wherein the polymer is selected from the group consisting of polyethylenes, polycarbonates, polyanhydrides, polyhydroxyacids, polypropylfumarates, polycaprolactones, polyamides, polyacetals, polyethers, polyesters, poly(orthoesters), polycyanoacrylates, polyvinyl alcohols, polyurethanes, polyphosphazenes, polyacrylates, polymethacrylates, polyureas, polystyrenes, polyamines, derivatives thereof, combinations thereof, and copolymers thereof. 14. The microfluidic system of claim 12, wherein the polymer is selected from the group consisting of polyethylene glycol (PEG); poly(lactic acid-co-glycolic acid); copolymers of poly(lactic acid-co-glycolic acid) and PEG; poly(lactide-co-glycolide); copolymers of poly(lactide-co-glycolide) and PEG; polyglycolic acid; copolymers of polyglycolic acid and PEG; poly-L-lactic acid; copolymers of poly-L-lactic acid and PEG; poly-D-lactic acid; copolymers of poly-D-lactic acid and PEG; poly-D,L-lactic acid; copolymers of poly-D,L-lactic acid and PEG; poly-L-lactide; copolymers of poly-L-lactide and PEG; poly-D-lactide; copolymers of poly-D-lactide and PEG; poly-D,L-lactide; copolymers of poly-D,L-lactide and PEG; poly(ortho ester); copolymers of poly(ortho ester) and PEG; poly(caprolactone); copolymers of poly(caprolactone) and PEG; polylysine; copolymers of polylysine and PEG; poly(ethylene imine); copolymers of poly(ethylene imine) and PEG; polyhydroxyacids; polyanhydrides; poly(L-lactide-co-L-lysine); poly(serine ester); poly(4-hydroxy-L-proline ester); poly[α-(4-aminobutyl)-L-glycolic acid]; derivatives thereof, combinations thereof, and copolymers thereof. 15. The microfluidic system of claim 12, wherein the polymer solvent is selected from the group consisting of 1,4 dioxane, tetrahydrofuran (THF), acetone, acetonitrile, dimethyl sulfoxide (DMSO), dimethylformamide (DMF), acids, and alcohols. 16. The microfluidic system of claim 12, wherein the polymer non-solvent fluid is an aqueous solution or water. 17. The microfluidic system of claim 12, wherein the polymeric solution further comprises at least one therapeutic agent to be encapsulated in the particles. 18. The microfluidic system of claim 1, wherein the channels are composed of a material selected from the group consisting of a metal, a polymer, photocurable epoxy, polydimethylsiloxane, glass, silicon, combinations thereof. 19. The microfluidic system of claim 1, wherein the channels are formed by lithography, embossing, or molding of a polymeric surface. 20. The microfluidic system of claim 1, the device further comprising an apparatus for controlling the temperature. 21. A method of producing particles in a microfluidic system comprising at least a central and an outer channel, each channel having a cross-section independently selected from the group consisting of circular, oval, ovaloid, elliptical, and ellipsoid shapes, that converge into a mixing apparatus, wherein the width and height of each channel is between approximately 1 μm and approximately 1000 μm, and means for controlling the flow rates through the channels either using pumps or applying pressure to focus the polymer solution into a narrow stream having a width which is smaller than the channel width within the mixing apparatus, or wherein the mixing apparatus is selected from the group consisting of chaotic advection mixers, zigzag mixers, droplet mixers, shear superposition mixers, T-mixers, mixers based on Tesla structures, and active mixers; comprising the steps of: flowing a polymeric solution not containing particles through the central channel, wherein the solution comprises at least one polymer and a solvent;flowing a non-solvent fluid not containing particles for the polymer through at least one outer channel; andmixing the polymeric solution with the polymer non-solvent in the mixing apparatus to form polymer particles.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (205)
Gerster John F. (Woodbury MN) Crooks Stephen L. (Mahtomedi MN) Lindstrom Kyle J. (Houlton WI), 1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines.
Schmitz,Juergen; Dzionek,Andrzej; Buck,David William, Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby.
Arimilli Murty N. ; Cundy Kenneth C. ; Dougherty Joseph P. ; Kim Choung U. ; Oliyai Reza ; Stella Valentino J., Antiviral phosphonomethoxy nucleotide analogs having increased oral bioavailability.
Hubbard Vance M. (Bedford) Brunson Welton K. (Bedford) Saied V. C. (Wichita Falls TX), Apparatus and method for raising a skin wheal and anesthetizing skin.
Flatt James H. ; Applegate Mark A. ; Peterson Alvin, Apparatus and method for sterilizing, seeding, culturing, storing, shipping and testing replacement cartilage tissue constructs.
Mikos Antonios G. (Houston TX) Sarakinos Georgios (Boston MA) Vacanti Joseph P. (Winchester MA) Langer Robert S. (Newton MA) Cima Linda G. (Lexington MA), Biocompatible polymer membranes and methods of preparation of three dimensional membrane structures.
Barrera Denise (Oakdale MN) Langer Robert S. (Newton MA) Lansbury ; Jr. Peter T. (Brookline MA) Vacanti Joseph P. (Winchester MA), Biodegradable polymers for cell transplantation.
Vacanti Joseph P. ; Vacanti Charles A. ; Langer Robert S., Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous struct.
D\Amore Patricia (Brookline MA) Leong Kam W. (Cambridge MA) Langer Robert S. (Somerville MA), Bioerodible articles useful as implants and prostheses having predictable degradation rates.
Skwierczynski Raymond D. ; Phares Kenneth R. ; Miller Richard L. ; Li Zheng Jane ; Jozwiakowski Michael J. ; Busch Terri F., Formulations and methods for treatment of mucosal associated conditions with an immune response modifier.
Dalton,James T.; Miller,Duane D.; Steiner,Mitchell S.; Veverka,Karen A., Halogenated selective androgen receptor modulators and methods of use thereof.
Swain Philip A. ; Schad Victoria C. ; Greenstein Julia L. ; Exley Mark A. ; Fox Barbara S. ; Powers Stephen P. ; Gefter Malcolm L., Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same.
Kedl,Ross M.; Griesgraber,George W.; Zarraga,Isidro Angelo E.; Wightman,Paul D., Immunostimulatory compositions and methods of stimulating an immune response.
Lilley Stephen J. (Sawston GBX) Taylor Hugh F. (Sawston GBX) Theobald David R. (Huntingdon GBX) Carlson Craig J. (Andover MA) Rosen David I. (Arlington MA) Johnson Thomas R. (Milford NH), Medical injection system and method, gas spring thereof and launching device using gas spring.
Tice Thomas R. ; Gilley Richard M. ; Eldridge John H. ; Staas Jay K., Method for delivering bioactive agents into and through the mucosally-associated lymphoid tissues and controlling their.
Bengs, Holger; Grande, Jürgen; Schuth, Silke; Böhm, Gitte; Schneller, Arnold; Brunner, Anette, Method for preparing smooth-surface spherical microparticles completely or partially made of at least one water-insoluble linear polysaccharide and microparticles produced according to this method.
Bomberger David C. ; Catz Paul G. ; Smedley Mark I. ; Stearns Paul C., Method for producing drug-loaded microparticles and an ICAM-1 dosage form so produced.
Deming, Timothy J.; Yu, Miaoer; Curtin, Scott A.; Hwang, Jungyeon; Wyrsta, Michael D.; Nowak, Andrew; Seidel, Scott W., Methods and compositions for controlled polypeptide synthesis.
Speaker Tully J. (Philadelphia PA) Sultzbaugh Kenneth J. (Philadelphia PA), Microcapsules of predetermined peptide(s) specificity (ies), their preparation and uses.
Jacobson Stephen C. ; Ramsey J. Michael, Microfabricated device and method for multiplexed electrokinetic focusing of fluid streams and a transport cytometry method using same.
Horoszewicz Julius S. (Williamsville NY), Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients.
Domb Abraham J. (Efrat ILX) Gref Ruxandra (Nancy FRX) Minamitake Yoshiharu (Ota JPX) Peracchia Maria T. (Parma ITX) Langer Robert S. (Newton MA), Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers.
Domb Abraham J.,ILX ; Gref Ruxandra,FRX ; Minamitake Yoshiharu,JPX ; Peracchia Maria Teresa,ITX ; Langer Robert S., Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers.
Mirkin, Chad A.; Letsinger, Robert L.; Mucic, Robert C.; Storhoff, James J.; Elghanian, Robert; Taton, Thomas A.; Garimella, Viswanadham; Li, Zhi, Nanoparticles having oligonucleotides attached thereto and uses therefor.
McKinnon ; Jr. Charles N. (Laguna Niguel CA) Peterson Steven F. (West Linn OR) Smith Paul E. (Tualatin OR) Nakagawa Takaaki (Tigard OR) Bartholomew Victor L. (Tigard OR), Needleless hypodermic injection device.
Peterson Steven F. (West Linn OR) McKinnon ; Jr. Charles N. (Laguna Niguel CA) Smith Paul E. (Tualatin OR) Nakagawa Takaaki (Tigard OR) Bartholomew Victor L. (Tigard OR), Needleless hypodermic injection methods and device.
Bischofberger Norbert W. ; Jones Robert J. ; Arimilli Murty N. ; Lin Kuei-Ying ; Louie Michael S. ; McGee Lawrence R. ; Prisbe Ernest J. ; Lee William A. ; Cundy Kenneth C., Nucleotide analogs.
Santus Giancarlo (Milan ITX) Bottoni Giuseppe (Bergamo ITX) Sala Giovanni (Verona ITX), Pharmaceutical controlled-release composition with bioadhesive properties.
DeLuca Patrick P. (Lexington KY) Kanke Motoko (Fukuyama JPX) Sato Toyomi (Tokyo CA JPX) Schroeder Hans G. (Encinitas CA), Porous microspheres for drug delivery and methods for making same.
Fessi Curt (Paris FRX) Devissaguet Jean-Philippe (Neuilly S/Seine FRX) Puisieux Francis (Maisons Alfort MO FRX) Thies Curt (St. Louis MO), Process for the preparation of dispersible colloidal systems of a substance in the form of nanoparticles.
Stainmesse Serge (Choisy le Roi FRX) Fessi Hatem (Paris FRX) Devissaguet Jean-Philippe (Neuilly sur Seine FRX) Puisieux Francis (Maisons-Alfort FRX), Process for the preparation of dispersible colloidal systems of amphiphilic lipids in the form of oligolamellar liposome.
Cech Thomas R. (Boulder CO) Zaug Arthur J. (Louisville CO) Been Michael D. (Boulder CO), RNA ribozyme polymerases, dephosphorylases, restriction endoribo-nucleases and methods.
Hirosue Sachiko ; Mueller Bernhard G.,CHX ; Langer Robert S. ; Mulligan Richard C., Sub-100nm biodegradable polymer spheres capable of transporting and releasing nucleic acids.
Larry Gold ; Michael Willis ; Tad Koch ; Steven Ringquist ; Kirk Jensen ; Brent Atkinson, Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands.
Gold Larry ; Willis Michael ; Koch Tad ; Ringquist Steven ; Jensen Kirk ; Atkinson Brent, Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex.
Gold Larry ; Willis Michael ; Koch Tad ; Ringquist Steven ; Jensen Kirk ; Atkinson Brent, Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex.
Kunz Lawrence L. ; Klein Richard A. ; Reno John M. ; Grainger David J.,GBX ; Metcalfe James C.,GBX ; Weissberg Peter L.,GBX ; Anderson Peter G., Therapeutic inhibitor of vascular smooth muscle cells.
Setterstrom, Jean A.; Tice, Thomas R.; Jacob, Elliot; Reid, Robert H.; van Hamont, John; Boedecker, Edgar C.; Jeyanthi, Ramassubbu; Friden, Phil; Roberts, F. Donald; McQueen, Charles E.; Bhattacharje, Therapeutic treatment and prevention of infections with a bioactive material(s) encapuslated within a biodegradable-bio-compatable polymeric matrix.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.